Prothena Corporation Plc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Prothena Corporation Plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer’s disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
/ 
Frequently asked questions
To buy Prothena Corporation Plc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Prothena Corporation Plc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Prothena Corporation Plc is PRTA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Prothena Corporation Plc has its primary listing on NASDAQ. You can trade Prothena Corporation Plc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Prothena Corporation Plc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Prothena Corporation Plc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Prothena Corporation Plc.